Clinical Trial

Ovarian PRP for Diminished Ovarian Reserve

Study acronym: oPRP
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 13, 2025 (before its estimated March 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-03-16.
Status change: Not Yet Recruiting → Recruiting 2025-02-11
Trial Details
NCT Number NCT05790655
Lead Sponsor Generation Next Fertility
Collaborators: Igenomix
Conditions Diminished Ovarian Reserve
Enrollment 230 participants
Start Date 2023-10-07
Primary Completion 2025-03-01 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-13